Anavex Life Sciences Corp (AVXL)

[tradeherpete]

Thanks for the article.

With the lack of efficacy combined with the certainty of adverse events you have to wonder what they were thinking. Not to mention the price.

'Living happier’

Daniel Gibbs, a 69-year-old retired neurologist with early-stage Alzheimer’s, was eager to participate in one of the Aduhelm trials. But after just four infusions, the Portland, Ore., physician wound up in the intensive care unit with explosive headaches and soaring blood pressure.

https://www.washingtonpost.com/health/2021/07/05/aduhelm-new-alzheimers-drug-amyloid/